Application of Quality Assurance Practices in Processing Cells and Tissues for Transplantation
Attention to issues of quality assurance from the early stages of development of experimental cell therapies provides a margin of safety for recipients. Adherence to minimum standards of practice at acquisition, processing, storage, and implantation ensures not only this baseline safety factor for p...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
1995-09-01
|
Series: | Cell Transplantation |
Online Access: | https://doi.org/10.1177/096368979500400506 |
id |
doaj-4c5404e0c09246dbb3d5ea05e0dc5111 |
---|---|
record_format |
Article |
spelling |
doaj-4c5404e0c09246dbb3d5ea05e0dc51112020-11-25T03:33:14ZengSAGE PublishingCell Transplantation0963-68971555-38921995-09-01410.1177/096368979500400506Application of Quality Assurance Practices in Processing Cells and Tissues for TransplantationHelen Newman-Gage0Northwest Tissue Center, A Department of the Puget Sound Blood Center, 921 Terry Avenue, Seattle, WA 98104; and Department of Orthopaedics, University of Washington, Seattle, WA 98195Attention to issues of quality assurance from the early stages of development of experimental cell therapies provides a margin of safety for recipients. Adherence to minimum standards of practice at acquisition, processing, storage, and implantation ensures not only this baseline safety factor for patients, but also provides a baseline for comparative evaluations between different studies or different banks. This paper describes the basic components of a quality assurance program tailored to laboratories and facilities that collect, process, or distribute human cells and tissues for transplantation. These components include policy and procedure manuals, donor screening practices, processing procedures evaluation and control, training and education programs, auditing and investigation roles, responsibility for release of grafts, and recordkeeping and traceability requirements. References and resources for detailed information related to good manufacturing practices and good clinical and laboratory practices are provided. Standards, regulations, and current legislation specifically related to human cells and tissues intended for transplantation are also discussed.https://doi.org/10.1177/096368979500400506 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Helen Newman-Gage |
spellingShingle |
Helen Newman-Gage Application of Quality Assurance Practices in Processing Cells and Tissues for Transplantation Cell Transplantation |
author_facet |
Helen Newman-Gage |
author_sort |
Helen Newman-Gage |
title |
Application of Quality Assurance Practices in Processing Cells and Tissues for Transplantation |
title_short |
Application of Quality Assurance Practices in Processing Cells and Tissues for Transplantation |
title_full |
Application of Quality Assurance Practices in Processing Cells and Tissues for Transplantation |
title_fullStr |
Application of Quality Assurance Practices in Processing Cells and Tissues for Transplantation |
title_full_unstemmed |
Application of Quality Assurance Practices in Processing Cells and Tissues for Transplantation |
title_sort |
application of quality assurance practices in processing cells and tissues for transplantation |
publisher |
SAGE Publishing |
series |
Cell Transplantation |
issn |
0963-6897 1555-3892 |
publishDate |
1995-09-01 |
description |
Attention to issues of quality assurance from the early stages of development of experimental cell therapies provides a margin of safety for recipients. Adherence to minimum standards of practice at acquisition, processing, storage, and implantation ensures not only this baseline safety factor for patients, but also provides a baseline for comparative evaluations between different studies or different banks. This paper describes the basic components of a quality assurance program tailored to laboratories and facilities that collect, process, or distribute human cells and tissues for transplantation. These components include policy and procedure manuals, donor screening practices, processing procedures evaluation and control, training and education programs, auditing and investigation roles, responsibility for release of grafts, and recordkeeping and traceability requirements. References and resources for detailed information related to good manufacturing practices and good clinical and laboratory practices are provided. Standards, regulations, and current legislation specifically related to human cells and tissues intended for transplantation are also discussed. |
url |
https://doi.org/10.1177/096368979500400506 |
work_keys_str_mv |
AT helennewmangage applicationofqualityassurancepracticesinprocessingcellsandtissuesfortransplantation |
_version_ |
1724563871063080960 |